Application of early non-invasive mechanical ventilation in the treatment of severe pneumonia
早期无创机械通气治疗重症肺炎的应用

摘要

目的 分析早期无创机械通气治疗重症肺炎的应用效果。方法 选择我院2019年3月至2022年3月重症肺炎患者共60例，随机数表随机分2组每组30例，对照组的患者给予常规治疗，联合组常规方法治疗联合BiPAP无创呼吸机治疗。比较两组气促症状消失时间、胸闷消失时间、咳嗽消失时间、治疗前后患者二氧化碳分压、血氧分压和血氧饱和度、呼吸频率、氧合指数、肺部炎症因子监测指标、总有效率、不良反应发生率。结果 联合组气促症状消失时间、胸闷消失时间、咳嗽消失时间短于对照组，总有效率高于对照组，P＜0.05。两组均无出现严重不良反应。治疗前二组患者血气分析指标、呼吸频率、氧合指数、肺部炎症因子监测指标比较，P＞0.05，而治疗后两组上述指标均改善，而联合组相关指标改善的程度高于对照组，P＜0.05。结论 常规方法联合BiPAP无创呼吸机对于重症肺炎的治疗效果确切，可有效改善患者的病情，促使其动脉血气指标，可一定程度控制肺部炎症发展，值得推广和应用。

Abstract

Objective To analyze the effect of early non-invasive mechanical ventilation in the treatment of severe pneumonia.
Methods A total of 60 patients with severe pneumonia in our hospital from March 2019 to March 2022 were selected and randomly divided into 2 groups with 30 cases in each group. treat. The disappearance time of shortness of breath symptoms, chest tightness disappearance time, cough disappearance time, carbon dioxide partial pressure, blood oxygen partial pressure and blood oxygen saturation, respiratory rate, oxygenation index, monitoring indicators of pulmonary inflammatory factors, total and efficiency and incidence of adverse reactions.
Results The disappearance time of shortness of breath, chest tightness and cough in the combination group were shorter than those in the control group, and the total effective rate was higher than that in the control group, P<0.05. There were no serious adverse reactions in either group. Before treatment, the comparison of blood gas analysis indexes, respiratory frequency, oxygenation index, and monitoring indexes of pulmonary inflammatory factors in the two groups of patients, P>0.05, and after treatment, the above indexes in the two groups were improved, and the improvement degree of related indexes in the combination group was higher than that in the control group , P<0.05.
Conclusion   The conventional method combined with BiPAP non-invasive ventilator is effective in the treatment of severe pneumonia, can effectively improve the patient's condition, promote arterial blood gas indicators, and control the development of pulmonary inflammation to a certain extent, which is worthy of promotion and application.